Monday, December 9, 2013

Added benefit of saxagliptin as monotherapy is not proven

No data on patients with metformin intolerance or contraindicationThe drug saxagliptin (trade name: Onglyza) has been approved also as monotherapy in Germany since July 2013 for certain adults with type 2 diabetes mellitus. It is an option when drug treatment is needed, but the drug metformin is not tolerated or cannot be used.

No comments:

Post a Comment